Showing results (81-90 of 143) with videos related to
Sort By:
Pageof 15
British Journal of Clinical Pharmacology|December 28, 2021
A systematic review of methods used to conduct decentralised clinical trialsAmy Rogers, Giorgia De Paoli, Selvarani Subbarayan, et al.Journal of Human Hypertension|March 3, 2021
Factors influencing home blood pressure monitor ownership in a large clinical trialThineskrishna Anbarasan, Amy Rogers, David A Rorie, et al.British Journal of Clinical Pharmacology|January 6, 2017
Acid-suppression medications and bacterial gastroenteritis: a population-based cohort studyLi Wei, Lasantha Ratnayake, Gabby Phillips, et al.Journal of Medical Internet Research|September 3, 2024
The Digital Platform and Its Emerging Role in Decentralized Clinical TrialsRachel R Copland, Sten Hanke, Amy Rogers, et al.Hypertension (Dallas, Tex. : 1979)|January 15, 2014
Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trialMiles D Witham, Sheila Ireland, J Graeme Houston, et al.Pilot and Feasibility Studies|March 12, 2022
Evaluating Diuretics in Normal Care (EVIDENCE): a feasibility report of a pilot cluster randomised trial of prescribing policy in primary care to compare the effectiveness of thiazide-type diuretics in hypertensionAngela Flynn, Amy Rogers, Lewis McConnachie, et al.Journal of Hypertension|December 17, 2009
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDOHari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.Trials|November 18, 2021
Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertensionAmy Rogers, Angela Flynn, Isla S Mackenzie, et al.BMC Cardiovascular Disorders|May 11, 2007
Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) studyHari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.BMJ Open|September 10, 2016
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART studyIsla S Mackenzie, Ian Ford, Andrew Walker, et al.Pageof 15